Rifampicin Export Market Intelligence: India's 175 Suppliers Shipping to 162 Countries — TransData Nexus 2026

Q: Who are the top rifampicin exporters from India?

The top rifampicin exporters from India are: 1. LUPIN LIMITED — $843.6M (62.5% market share); 2. MACLEODS PHARMACEUTICALS LTD — $450.4M (33.4% market share); 3. MACLEODS PHARMACEUTICALS LIMITED — $18.5M (1.4% market share); 4. MANEESH PHARMACEUTICALS LIMITED — $15.2M (1.1% market share); 5. SVIZERA LABS PRIVATE LIMITED — $7.2M (0.5% market share). Together they account for 98.9% of India's total rifampicin export value.

Q: What is the total export value of rifampicin from India?

The total export value of rifampicin from India is $1.3B USD, recorded across 3,913 shipment transactions from 175 active exporters to 162 destination countries. The average shipment value is $344.9K.

Q: Which countries import rifampicin from India?

India exports rifampicin to 162 countries worldwide. The top importing countries are: CONGO DR (39.7% share, $536.0M), NIGERIA (18.7% share, $252.7M), TUNISIA (10.7% share, $145.1M), BANGLADESH (7.1% share, $96.2M), ZIMBABWE (4.5% share, $60.7M). These five markets account for 80.8% of total export value.

Q: What is the HS code for rifampicin exports from India?

The primary HS code for rifampicin exports from India is 30049057. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of rifampicin exports from India?

The average unit price for rifampicin exports from India is $6.47 USD per unit, with prices ranging from $0.00 to $192.43 depending on formulation, packaging, and order volume. The total market is valued at $1.3B across 3,913 shipments.

Q: Which ports handle rifampicin exports from India?

The primary ports for rifampicin exports from India are SAHAR AIR CARGO ACC (INBOM4) (24.2% of shipments), SAHAR AIR (20.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (12.2% of shipments), DELHI AIR (10.3% of shipments), NHAVA SHEVA SEA (INNSA1) (7.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of rifampicin?

India is one of the world's leading exporters of rifampicin due to its large base of 175 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports rifampicin to 162 countries, demonstrating 83% global market coverage.

Q: What certifications do Indian rifampicin exporters need?

Indian rifampicin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import rifampicin from India?

There are 780 registered buyers importing rifampicin from India, spread across 162 countries. The repeat buyer rate is 67.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top rifampicin supplier from India?

LUPIN LIMITED is the leading rifampicin exporter from India with a market share of 62.5% and total export value of $843.6M across 369 shipments. The top 5 suppliers together control 98.9% of total export value.

Suresh Sormare

Rifampicin

India Pharmaceutical Trade Intelligence

$1.3B175 Suppliers162 CountriesHS 30049057

ExportsIndia → CONGO DR39.7%India → NIGERIA18.7%

ImportsUNITED STATES → India$125.6K UNITED KINGDOM → India$10.2K

#1 Supplier: LUPIN LIMITED #1 Buyer: CAMESKIN/CORDAID

Rifampicin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Rifampicin to the World

Between 2022 and 2026, India exported $1.3B worth of rifampicin across 3,913 verified shipments to 162 countries — covering 83% of world markets in the Advanced Antibiotics segment. The largest destination is CONGO DR (39.7%). LUPIN LIMITED leads with a 62.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Rifampicin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Rifampicin export data snapshot — $1.3B · 175 exporters · 162 countriesTransData Nexus · Indian Customs Data

Top Rifampicin Exporters from India

175 active exporters · Ranked by export value

View all 175 →

Top Rifampicin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LUPIN LIMITED	$843.6M	369	58	62.5%
2	MACLEODS PHARMACEUTICALS LTD

Top Countries Importing Rifampicin from India

162 destination markets · Ranked by import value

All 162 countries →

Top Countries Importing Rifampicin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	CONGO DR	$536.0M	39.7%
2	NIGERIA	$252.7M	18.7%
3	TUNISIA	$145.1M	10.7%
4	BANGLADESH	$96.2M	7.1%
5	ZIMBABWE	$60.7M	4.5%
6	UNITED STATES	$26.4M	2.0%
7	SOUTH AFRICA	$25.4M	1.9%
8	SRI LANKA	$21.9M	1.6%
9	PARAGUAY	$20.8M	1.5%
10	NETHERLANDS	$12.7M	0.9%

CONGO DR is India's largest rifampicin export destination, absorbing 39.7% of total exports worth $536.0M. The top 5 importing countries — CONGO DR, NIGERIA, TUNISIA, BANGLADESH, ZIMBABWE — together account for 80.8% of India's total rifampicin export value. The remaining 157 destination countries collectively receive the other 19.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Rifampicin to India?

8 origin countries · Total import value: $150.5K

India imports rifampicin from 8 countries with a combined import value of $150.5K. The largest supplier is UNITED STATES ($125.6K, 13 shipments), followed by UNITED KINGDOM and ITALY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Rifampicin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$125.6K	13	83.4%
2	UNITED KINGDOM	$10.2K	8	6.7%
3	ITALY	$6.7K	4	4.5%
4	IRELAND	$4.1K	2	2.7%
5	BELGIUM	$1.5K	27	1.0%
6	SWITZERLAND	$1.4K	2	0.9%
7	SOUTH AFRICA	$942	2	0.6%
8	PAKISTAN	$121	3	0.1%

UNITED STATES is the largest supplier of rifampicin to India, accounting for 83.4% of total import value. The top 5 origin countries — UNITED STATES, UNITED KINGDOM, ITALY, IRELAND, BELGIUM — together supply 98.3% of India's rifampicin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Rifampicin — Export Intelligence Video

Visual overview of India's rifampicin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's rifampicin pharmaceutical import and export market — $1.3B in total trade, 175 verified manufacturers, and 162 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Rifampicin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, rifampicin is approved for use under the brand name Rifadin, with multiple generic versions available. The FDA's Orange Book lists several approved Abbreviated New Drug Applications (ANDAs) for rifampicin, indicating a competitive generic market. As of March 2026, there are no active FDA import alerts specifically targeting rifampicin imports from India, suggesting compliance with U.S. regulatory standards. Given the presence of 175 active Indian exporters, it is imperative for each to adhere strictly to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, rifampicin is authorized for use in combination therapies for tuberculosis treatment. The European Medicines Agency (EMA) conducted a Periodic Safety Update Report Single Assessment (PSUSA) for rifampicin, resulting in a variation to its marketing authorization in December 2025. This underscores the importance of ongoing pharmacovigilance and compliance with EU Good Manufacturing Practice (GMP) requirements. Similarly, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, necessitating that Indian exporters ensure their manufacturing processes meet these stringent criteria.

3WHO Essential Medicines & Global Standards

Rifampicin is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its critical role in global health. The WHO has also addressed concerns regarding nitrosamine impurities in rifampicin medicines, emphasizing the need for rigorous quality control measures. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for Indian exporters to ensure product quality and safety.

4India Regulatory Classification

In India, rifampicin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for rifampicin formulations to ensure affordability; the latest revision was in January 2026. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to regulate and monitor the export of essential medicines, ensuring domestic availability is not compromised.

5Patent & Exclusivity Status

The primary patents for rifampicin have expired, leading to a robust generic market with significant competition. This competitive landscape is reflected in the substantial export activities from India, with multiple manufacturers supplying to various international markets.

6Recent Industry Developments

In December 2025, the EMA recommended a variation to the marketing authorization for rifampicin-containing medicines following a Periodic Safety Update Report Single Assessment, emphasizing the need for continuous monitoring of safety profiles. In January 2026, the NPPA revised the ceiling price for rifampicin formulations to ensure affordability and accessibility within the Indian market. Additionally, in February 2026, the WHO issued updated guidelines addressing nitrosamine impurities in rifampicin, urging manufacturers to implement stringent quality control measures to mitigate potential risks.

These developments underscore the dynamic regulatory environment surrounding rifampicin, necessitating that Indian exporters remain vigilant and compliant with both domestic and international standards to sustain and expand their market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Rifampicin

Retail & reference prices across 9 markets vs. India FOB export price of $6.47/unit

Global Price Benchmark for Rifampicin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	The U.S. Food and Drug Administration (FDA) does not publish drug pricing information.
United Kingdom	N/A	GBP	The UK's National Health Service (NHS) Drug Tariff does not list Rifampicin 500 mg tablets separately.
Germany	N/A	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) does not provide public pricing data for individual medications.
Australia	N/A

Supply Chain Risk Assessment — Rifampicin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) synthesis. Approximately 60–70% of KSMs and intermediates are imported from China, making India vulnerable to supply chain disruptions. This dependency is particularly critical for antibiotics like Rifampicin, where the unavailability of specific KSMs can halt production.

Recent events have highlighted this vulnerability. In March 2026, the Strait of Hormuz crisis led to significant disruptions in global shipping routes, causing delays and increased costs for raw material imports. Such geopolitical tensions underscore the risks associated with over-reliance on a single source for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in India's Rifampicin exports. The top five exporters account for 98.9% of the total export value, with LUPIN LIMITED alone contributing 62.5%. This concentration poses a significant risk; any operational or compliance issues within these key suppliers could disrupt the entire supply chain.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2021, aiming to boost domestic API and KSM production. By November 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and 6-APA. While these initiatives are steps toward reducing dependency, the current supplier concentration remains a concern.

Access Complete Rifampicin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,913 transactions across 162 markets.

Request Demo View Pricing

Frequently Asked Questions — Rifampicin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top rifampicin exporters from India?

The leading rifampicin exporters from India are LUPIN LIMITED, MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, and 12 others. LUPIN LIMITED leads with 62.5% market share ($843.6M). The top 5 suppliers together control 98.9% of total export value.

What is the total export value of rifampicin from India?

The total export value of rifampicin from India is $1.3B, recorded across 3,913 shipments from 175 active exporters to 162 countries. The average shipment value is $344.9K.

Which countries import rifampicin from India?

India exports rifampicin to 162 countries. The top importing countries are CONGO DR (39.7%), NIGERIA (18.7%), TUNISIA (10.7%), BANGLADESH (7.1%), ZIMBABWE (4.5%), which together account for 80.8% of total export value.

What is the HS code for rifampicin exports from India?

The primary HS code for rifampicin exports from India is 30049057. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rifampicin

Rifampicin

Top Rifampicin Exporters from India

Top Countries Importing Rifampicin from India

Who Supplies Rifampicin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Rifampicin — Export Intelligence Video

Regulatory Landscape — Rifampicin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Rifampicin

Supply Chain Risk Assessment — Rifampicin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Rifampicin Trade Intelligence

Frequently Asked Questions — Rifampicin Exports from India

Who are the top rifampicin exporters from India?

What is the total export value of rifampicin from India?

Which countries import rifampicin from India?

What is the HS code for rifampicin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of rifampicin exports from India?

Which ports handle rifampicin exports from India?

Why is India a leading exporter of rifampicin?

What certifications do Indian rifampicin exporters need?

How many buyers import rifampicin from India?

What is the market share of the top rifampicin exporter from India?

Analysis Methodology